Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-05 Sale | 2024-01-08 6:01 pm | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 9,799 | $10.79 | $105,699 | 191,701 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-05 Exercise | 2024-01-08 6:01 pm | N/A N/A | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 17,166 | $0 | 191,701 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-08 6:01 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 150,000 | $0 | 191,701 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 129,000 | $0 | 129,000 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-19 9:05 pm | N/A 2032-07-17 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |